Client: Callaghan Innovation
Market Sector: Science & Research
Completion: July 2023
Location: Wellington, New Zealand
The new PC2 (Physical Containment Level 2) facility is located in Wellington at Callaghan Innovation's Gracefield Innovation Quarter. State-of the-art laboratory is for BioViros, a full-service CDMO (Contract Development and Manufacturing Organization), specializing in lentiviral vectors for cell and gene therapy.
BioViros will manufacture customized vectors, highly optimized for developing early-stage cell and gene therapies to treat various diseases such as cancer.